MetaSafe Welcomes New Master’s Thesis Student

MetaSafe is delighted to welcome a new Master’s student who will begin his thesis project on 9 September 2026. The project will focus on nitrosamine metabolism, which is of toxicological relevance due to the potential bioactivation of nitrosamines into...

Meet MetaSafe at Nordic Life Science Days 2026

MetaSafe will be attending Nordic Life Science Days (NLSDays) in Stockholm on 8-9 September 2026. As one of the largest partnering and networking events for the Nordic life science community, NLSDays provides a valuable platform for connecting with pharmaceutical...

Scientific Manuscript Submitted for Peer Review

MetaSafe is pleased to announce the submission of a new scientific manuscript to an international peer-reviewed journal. The work represents the culmination of extensive research efforts and highlights our commitment to advancing knowledge within the field of chemical...

Strong First Half-Year with Critical Met-ID Deliveries

As we reach the midpoint of 2026, MetaSafe is proud to reflect on a highly productive first half of the year. During the past six months, we have successfully delivered several critical metabolite identification (Met-ID) studies supporting pharmaceutical development...

Exploring Innovations and Laboratory Trends at Lab Days

During April, MetaSafe participated in Lab Days, one of the leading events for laboratory professionals, suppliers, and scientists. The event provided an excellent opportunity to explore emerging technologies, discuss industry challenges, and gain insights into future...

Successful Delivery of Key Exposure Measurement Projects

MetaSafe is pleased to report the successful completion of several important projects involving chemical exposure measurements. These deliveries supported our clients in assessing occupational and environmental exposure to compounds of regulatory and toxicological...